Stock Updates

Today’s Top Gainers in the Market Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Healthcare

Today’s top gainers include the company Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is in the industry Biotechnology, gaining 4.23% today. In the last week its performance is -4.09%, and 4.74% for the past quarter. Currently, Regeneron Pharmaceuticals, Inc., REGN has a target price of 466.64, so today’s gain of 4.23% is a significant step towards its target price. The GAP today is therefore 0.62%.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), has a market cap of 43264.14, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 71.00%.

At the current price of 421.39, it has a dividend yield of *TBA, and its target price is 466.64. This is with a profit margin of 19.50%, and total debt/equity of 0.09. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a P/E of 63.11, as well as a forward P/E of 28.02.

With a current EPS of 6.41, and a forecasted EPS growth for next year at 31.79%,Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has had a EPS growth for the past five years at 44.90%. For the next five years EPS growth is projected to be 18.62%.

Performance for the year is -26.04%. Since its IPO date on 4/2/1991, the total performance to date is -25.53%.

Volume today for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), is 556368, while its average volume is 842.55. Whilst the total gain today was 4.23%, it did have a day high of -5.09%.

Volatility for this week has been at 1.58%, and 2.39% for the month. The 52-week low for Regeneron Pharmaceuticals, Inc., REGN has been 28.05%, while the 52-week-high has reached -28.89%.

Looking at its return of investments, which is 16.00%, and its return on assets is 15.90%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an operating margin of 33.80%. With a sales growth of 21.40% quarter over quarter. Bearing in mind that Regeneron Pharmaceuticals, Inc., REGN is in the sector Healthcare, its long-term debt/equity is 0.09, and has a current ratio of 3.4 and 3.1 for quick ratio.

So what is the value of Regeneron Pharmaceuticals, Inc.? Well its PEG is 3.39, and the P/S is 9.31, along with a P/B of 10.38. Meanwhile it has a p/cash of 41.39.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment